Clinical Trials Logo

Filter by:
NCT ID: NCT00121784 Terminated - Clinical trials for Heart Transplantation

Heart Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Heart Transplant Recipients

Start date: October 2005
Phase: Phase 4
Study type: Interventional

Heart transplant patients on a standard care regimen of CNI, MMF, and corticosteroids will enter the study 4-6 weeks post-transplant. At 3 months after transplant, patients will be randomized to either continue this regimen or CNI therapy will be discontinued and replaced by sirolimus therapy (in combination with MMF and corticosteroids). The effect of these 2 regimens on efficacy, safety and renal function will be evaluated.The anticipated time on study treatment is 1-2 years and the target sample size is 500+ individuals.

NCT ID: NCT00120783 Terminated - HIV Infections Clinical Trials

Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug Resistance

Start date: February 2002
Phase: Phase 2
Study type: Interventional

This study investigated whether a calibrated reduction in antiretroviral drug pressures could stabilize the evolution and the pathogenic potential of resistant HIV viruses.

NCT ID: NCT00119119 Terminated - Clinical trials for Hepatitis C, Chronic

Efficacy and Safety of Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis C

Start date: February 2002
Phase: Phase 3
Study type: Interventional

The fibrosis of liver is a complication of chronic hepatitis C. There is actually no established treatment for fibrosis of the liver. Pentoxyphilline and tocopherol may have an activity on fibrosis. The aim of the study is to analyse the efficacy and the safety of the combination with pentoxyphilline and tocopherol (12 months) on liver fibrosis, in patients with chronic hepatitis C, who are non-long-term responders, or with intolerance or contra-indication to interferon-alfa and ribavirin.

NCT ID: NCT00118573 Terminated - Clinical trials for Aortic Aneurysm, Abdominal

Comparison of Surveillance Versus Aortic Endografting for Small Aneurysm Repair

CAESAR
Start date: September 2004
Phase: Phase 4
Study type: Interventional

Objective of the present study is to compare endovascular repair versus surveillance and, eventually delay treatment in patients with small abdominal aortic aneurysms (AAA), with respect to patient survival, AAA rupture and AAA related death risks.

NCT ID: NCT00104624 Terminated - Breast Cancer Clinical Trials

Docetaxel in Treating Older Women With Metastatic Breast Cancer

Start date: May 2005
Phase: Phase 2
Study type: Interventional

RATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well docetaxel works in treating older women with metastatic breast cancer and whether it helps improve the ability to perform daily activities.

NCT ID: NCT00104429 Terminated - HIV Infection Clinical Trials

GW873140 In Combination With Combivir In HIV Infected Subjects

Start date: January 2005
Phase: Phase 2
Study type: Interventional

This study is a 96-week study designed to evaluate the safety and efficacy of GW873140 in combination with Combivir in HIV infected, untreated subjects.

NCT ID: NCT00102791 Terminated - Sickle Cell Disease Clinical Trials

A Stratified Sickle Event Randomized Trial (ASSERT)

ASSERT
Start date: February 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the effects of ICA-17043 to placebo with or without hydroxyurea (an oral drug used for treatment of sickle cell disease) in patients with sickle cell disease who have had 2 or more acute sickle-related painful crises requiring a visit to a medical facility within the past 12 months.

NCT ID: NCT00102778 Terminated - HIV Infection Clinical Trials

GW873140 In Combination With Kaletra In HIV Infected Subjects

Start date: December 2004
Phase: Phase 2
Study type: Interventional

This study is a 96-week study designed to evaluate the safety and efficacy of GW873140 in combination with Kaletra in HIV infected, untreated subjects.

NCT ID: NCT00102128 Terminated - Clinical trials for Ischemic Heart Disease

Study to Examine the Safety and Effectiveness of Implanted Skeletal Muscle Cells (Cells Removed From the Thigh Muscle) Into Scarred Areas of Heart Muscle After Heart Attack.

Start date: November 2002
Phase: Phase 2
Study type: Interventional

Study to examine the safety and effectiveness of implanted skeletal muscle cells (cells removed from the thigh muscle) into scarred areas of heart muscle after heart attack.

NCT ID: NCT00099879 Terminated - Clinical trials for Non-small Cell Lung Cancer

Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer

Start date: n/a
Phase: Phase 2
Study type: Interventional

The purpose of this clinical research study is to learn if BMS-275183 can shrink or slow the growth of the cancer in subjects with non-small cell lung cancer (NSCLC). The safety of this treatment will also be studied.